Literature DB >> 18641635

A small molecule enhances RNA interference and promotes microRNA processing.

Ge Shan1, Yujing Li, Junliang Zhang, Wendi Li, Keith E Szulwach, Ranhui Duan, Mohammad A Faghihi, Ahmad M Khalil, Lianghua Lu, Zain Paroo, Anthony W S Chan, Zhangjie Shi, Qinghua Liu, Claes Wahlestedt, Chuan He, Peng Jin.   

Abstract

Small interfering RNAs (siRNAs) and microRNAs (miRNAs) are sequence-specific post-transcriptional regulators of gene expression. Although major components of the RNA interference (RNAi) pathway have been identified, regulatory mechanisms for this pathway remain largely unknown. Here we demonstrate that the RNAi pathway can be modulated intracellularly by small molecules. We have developed a cell-based assay to monitor the activity of the RNAi pathway and find that the small-molecule enoxacin (Penetrex) enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. We show that this RNAi-enhancing activity depends on the trans-activation-responsive region RNA-binding protein. Our results provide a proof-of-principle demonstration that small molecules can be used to modulate the activity of the RNAi pathway. RNAi enhancers may be useful in the development of research tools and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641635      PMCID: PMC2831467          DOI: 10.1038/nbt.1481

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  29 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.

Authors:  Ranhui Duan; Changhui Pak; Peng Jin
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

4.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

Review 5.  Immunomodulatory effects of quinolones.

Authors:  Axel Dalhoff; Itamar Shalit
Journal:  Lancet Infect Dis       Date:  2003-06       Impact factor: 25.071

6.  Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis.

Authors:  Emily Eriksson; Arne Forsgren; Kristian Riesbeck
Journal:  J Leukoc Biol       Date:  2003-09       Impact factor: 4.962

7.  A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

Authors:  Gustavo Tiscornia; Oded Singer; Masahito Ikawa; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

Review 8.  The expanding role of fluoroquinolones.

Authors:  Anthony J Schaeffer
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

9.  A microRNA in a multiple-turnover RNAi enzyme complex.

Authors:  György Hutvágner; Phillip D Zamore
Journal:  Science       Date:  2002-08-01       Impact factor: 47.728

10.  Sequence-specific inhibition of small RNA function.

Authors:  György Hutvágner; Martin J Simard; Craig C Mello; Phillip D Zamore
Journal:  PLoS Biol       Date:  2004-02-24       Impact factor: 8.029

View more
  106 in total

Review 1.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

2.  HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites.

Authors:  Priya S Shah; Nhung P Pham; David V Schaffer
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

3.  Targeting microRNAs with small molecules: from dream to reality.

Authors:  S Zhang; L Chen; E J Jung; G A Calin
Journal:  Clin Pharmacol Ther       Date:  2010-04-28       Impact factor: 6.875

4.  MicroRNAs in ALS: small pieces to the puzzle.

Authors:  Silvia Bicker; Gerhard Schratt
Journal:  EMBO J       Date:  2015-09-14       Impact factor: 11.598

Review 5.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

6.  Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.

Authors:  Jiangbing Zhou; Toral R Patel; Michael Fu; James P Bertram; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

Review 7.  Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.

Authors:  Rengen Fan; Chaocheng Xiao; Xinqiang Wan; Wenzhang Cha; Yufeng Miao; Yong Zhou; Chenglin Qin; Ting Cui; Fenglian Su; Xiangxiang Shan
Journal:  RNA Biol       Date:  2019-04-03       Impact factor: 4.652

Review 8.  Noncoding RNA for Cancer Gene Therapy.

Authors:  Xiaomin Zhong; Dongmei Zhang; Minmin Xiong; Lin Zhang
Journal:  Recent Results Cancer Res       Date:  2016

Review 9.  MicroRNAs as novel endogenous targets for regulation and therapeutic treatments.

Authors:  Wenzhang Cha; Rengen Fan; Yufeng Miao; Yong Zhou; Chenglin Qin; Xiangxiang Shan; Xinqiang Wan; Ting Cui
Journal:  Medchemcomm       Date:  2017-12-11       Impact factor: 3.597

10.  A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.

Authors:  Kyuri Kim; Zeynep Madak-Erdogan; Rosa Ventrella; Benita S Katzenellenbogen
Journal:  Horm Cancer       Date:  2012-12-19       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.